Clinical Trial Update: S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating carboplatin and paclitaxel with/without bevacizumab and/or cetuximab in stage IV or recurrent non-small cell lung cancer; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• Cetuximab (cetuximab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Recurrent Large Cell Lung Carcinoma, Recurrent Lung Adenocarcinoma | Phase 3 | Status: TERMINATED | Results posted: 2019-03-07